• Je něco špatně v tomto záznamu ?

CAIX-Mediated Control of LIN28/let-7 Axis Contributes to Metabolic Adaptation of Breast Cancer Cells to Hypoxia

A. Gibadulinova, P. Bullova, H. Strnad, K. Pohlodek, D. Jurkovicova, M. Takacova, S. Pastorekova, E. Svastova

. 2020 ; 21 (12) : . [pub] 20200616

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012470

Grantová podpora
14-0816 Agentúra na Podporu Výskumu a Vývoja
15-0697 Agentúra na Podporu Výskumu a Vývoja
2/0155/15 Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
2/0076/20 Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
2/0105/19 Vedecká Grantová Agentúra MŠVVaŠ SR a SAV

Solid tumors, including breast cancer, are characterized by the hypoxic microenvironment, extracellular acidosis, and chemoresistance. Hypoxia marker, carbonic anhydrase IX (CAIX), is a pH regulator providing a selective survival advantage to cancer cells through intracellular neutralization while facilitating tumor invasion by extracellular acidification. The expression of CAIX in breast cancer patients is associated with poor prognosis and metastases. Importantly, CAIX-positive hypoxic tumor regions are enriched in cancer stem cells (CSCs). Here we investigated the biological effects of CA9-silencing in breast cancer cell lines. We found that CAIX-downregulation in hypoxia led to increased levels of let-7 (lethal-7) family members. Simultaneously with the increase of let-7 miRNAs in CAIX-suppressed cells, LIN28 protein levels decreased, along with downstream metabolic pathways: pyruvate dehydrogenase kinase 1 (PDK1) and phosphorylation of its substrate, pyruvate dehydrogenase (PDH) at Ser-232, causing attenuation of glycolysis. In addition to perturbed glycolysis, CAIX-knockouts, in correlation with decreased LIN28 (as CSC reprogramming factor), also exhibit reduction of the further CSC-associated markers NANOG (Homeobox protein NANOG) and ALDH1 (Aldehyde dehydrogenase isoform 1). Oppositely, overexpression of CAIX leads to the enhancement of LIN28, ALDH1, and NANOG. In conclusion, CAIX-driven regulation of the LIN28/let-7 axis augments glycolytic metabolism and enhances stem cell markers expression during CAIX-mediated adaptation to hypoxia and acidosis in carcinogenesis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012470
003      
CZ-PrNML
005      
20210507102613.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21124299 $2 doi
035    __
$a (PubMed)32560271
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Gibadulinova, Adriana $u Department of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia
245    10
$a CAIX-Mediated Control of LIN28/let-7 Axis Contributes to Metabolic Adaptation of Breast Cancer Cells to Hypoxia / $c A. Gibadulinova, P. Bullova, H. Strnad, K. Pohlodek, D. Jurkovicova, M. Takacova, S. Pastorekova, E. Svastova
520    9_
$a Solid tumors, including breast cancer, are characterized by the hypoxic microenvironment, extracellular acidosis, and chemoresistance. Hypoxia marker, carbonic anhydrase IX (CAIX), is a pH regulator providing a selective survival advantage to cancer cells through intracellular neutralization while facilitating tumor invasion by extracellular acidification. The expression of CAIX in breast cancer patients is associated with poor prognosis and metastases. Importantly, CAIX-positive hypoxic tumor regions are enriched in cancer stem cells (CSCs). Here we investigated the biological effects of CA9-silencing in breast cancer cell lines. We found that CAIX-downregulation in hypoxia led to increased levels of let-7 (lethal-7) family members. Simultaneously with the increase of let-7 miRNAs in CAIX-suppressed cells, LIN28 protein levels decreased, along with downstream metabolic pathways: pyruvate dehydrogenase kinase 1 (PDK1) and phosphorylation of its substrate, pyruvate dehydrogenase (PDH) at Ser-232, causing attenuation of glycolysis. In addition to perturbed glycolysis, CAIX-knockouts, in correlation with decreased LIN28 (as CSC reprogramming factor), also exhibit reduction of the further CSC-associated markers NANOG (Homeobox protein NANOG) and ALDH1 (Aldehyde dehydrogenase isoform 1). Oppositely, overexpression of CAIX leads to the enhancement of LIN28, ALDH1, and NANOG. In conclusion, CAIX-driven regulation of the LIN28/let-7 axis augments glycolytic metabolism and enhances stem cell markers expression during CAIX-mediated adaptation to hypoxia and acidosis in carcinogenesis.
650    _2
$a antigeny nádorové $x genetika $7 D000951
650    _2
$a nádory prsu $x genetika $x metabolismus $7 D001943
650    _2
$a karboanhydrasa IX $x genetika $7 D000071231
650    _2
$a hypoxie buňky $7 D015687
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a přeprogramování buněk $7 D065150
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a glykolýza $7 D006019
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a mikro RNA $x genetika $7 D035683
650    _2
$a nádorové kmenové buňky $x metabolismus $7 D014411
650    _2
$a proteiny vázající RNA $x genetika $7 D016601
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bullova, Petra $u Department of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia
700    1_
$a Strnad, Hynek $u Institute of Molecular Genetics, The Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic
700    1_
$a Pohlodek, Kamil $u 2nd Department of Gynecology and Obstetrics, Faculty of Medicine, Comenius University of Bratislava, Ruzinovska 6, 821 01 Bratislava, Slovakia
700    1_
$a Jurkovicova, Dana $u Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia
700    1_
$a Takacova, Martina $u Department of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia
700    1_
$a Pastorekova, Silvia $u Department of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia
700    1_
$a Svastova, Eliska $u Department of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 12 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32560271 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102612 $b ABA008
999    __
$a ok $b bmc $g 1650767 $s 1132849
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 12 $e 20200616 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 14-0816 $p Agentúra na Podporu Výskumu a Vývoja
GRA    __
$a 15-0697 $p Agentúra na Podporu Výskumu a Vývoja
GRA    __
$a 2/0155/15 $p Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
GRA    __
$a 2/0076/20 $p Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
GRA    __
$a 2/0105/19 $p Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace